Bob Hopkins
Stock Analyst at B of A Securities
(1.17)
# 3,450
Out of 4,754 analysts
60
Total ratings
62.22%
Success rate
-16.41%
Average return
Main Sectors:
Stocks Rated by Bob Hopkins
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Upgrades: Buy | $220 → $255 | $182.44 | +39.77% | 5 | Nov 20, 2024 | |
| BSX Boston Scientific | Maintains: Buy | $90 → $100 | $104.87 | -4.64% | 5 | Oct 22, 2024 | |
| SGHT Sight Sciences | Downgrades: Underperform | $10 → $4.5 | $2.51 | +79.28% | 4 | Sep 13, 2023 | |
| PRCT PROCEPT BioRobotics | Initiates: Buy | $48 | $60.60 | -20.79% | 1 | Oct 11, 2021 | |
| ABT Abbott Laboratories | Maintains: Buy | $133 | $140.22 | -5.15% | 2 | Aug 31, 2021 | |
| LUNG Pulmonx | Upgrades: Buy | $72 | $8.29 | +768.52% | 2 | Mar 10, 2021 | |
| ISRG Intuitive Surgical | Downgrades: Neutral | $242 → $253 | $566.98 | -55.32% | 7 | Sep 8, 2020 | |
| PEN Penumbra | Downgrades: Neutral | n/a | $285.88 | - | 2 | Sep 8, 2020 | |
| TNDM Tandem Diabetes Care | Maintains: Neutral | $85 → $95 | $20.78 | +357.17% | 5 | May 22, 2020 | |
| JNJ Johnson & Johnson | Upgrades: Buy | n/a | $167.28 | - | 2 | Apr 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $37 → $30 | $103.03 | -70.88% | 2 | Oct 31, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 → $74 | $5.72 | +1,193.71% | 5 | Aug 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $105 | $94.30 | +11.35% | 7 | Aug 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $73 → $83 | $34.86 | +138.10% | 6 | May 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $260 | $228.45 | +13.81% | 4 | Jan 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $79.25 | - | 1 | Nov 10, 2017 |
Inspire Medical Systems
Nov 20, 2024
Upgrades: Buy
Price Target: $220 → $255
Current: $182.44
Upside: +39.77%
Boston Scientific
Oct 22, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $104.87
Upside: -4.64%
Sight Sciences
Sep 13, 2023
Downgrades: Underperform
Price Target: $10 → $4.5
Current: $2.51
Upside: +79.28%
PROCEPT BioRobotics
Oct 11, 2021
Initiates: Buy
Price Target: $48
Current: $60.60
Upside: -20.79%
Abbott Laboratories
Aug 31, 2021
Maintains: Buy
Price Target: $133
Current: $140.22
Upside: -5.15%
Pulmonx
Mar 10, 2021
Upgrades: Buy
Price Target: $72
Current: $8.29
Upside: +768.52%
Intuitive Surgical
Sep 8, 2020
Downgrades: Neutral
Price Target: $242 → $253
Current: $566.98
Upside: -55.32%
Penumbra
Sep 8, 2020
Downgrades: Neutral
Price Target: n/a
Current: $285.88
Upside: -
Tandem Diabetes Care
May 22, 2020
Maintains: Neutral
Price Target: $85 → $95
Current: $20.78
Upside: +357.17%
Johnson & Johnson
Apr 22, 2020
Upgrades: Buy
Price Target: n/a
Current: $167.28
Upside: -
Oct 31, 2019
Maintains: Underperform
Price Target: $37 → $30
Current: $103.03
Upside: -70.88%
Aug 9, 2019
Reiterates: Buy
Price Target: $70 → $74
Current: $5.72
Upside: +1,193.71%
Aug 22, 2018
Maintains: Buy
Price Target: $98 → $105
Current: $94.30
Upside: +11.35%
May 22, 2018
Maintains: Buy
Price Target: $73 → $83
Current: $34.86
Upside: +138.10%
Jan 19, 2018
Reinstates: Buy
Price Target: $260
Current: $228.45
Upside: +13.81%
Nov 10, 2017
Upgrades: Neutral
Price Target: n/a
Current: $79.25
Upside: -